ПAРКИНСОН КAСAЛЛИГИДA НОМОТОР БУЗИЛИШЛAР ВA УЛAРНИ ДAВОЛAШ УСУЛЛAРИ
##article.subject##:
Паркинсон касаллиги, номотор бузилишлар, коморбид ҳолатлар, беморларнинг ҳаёт сифати.##article.abstract##
Паркинсон касаллигида номотор бузилишлар кўп учрайди ва бу коморбид ҳолатлар беморларнинг ҳаёт сифатини пасайтиради. Юқорида айтиб ўтилганларга асосланиб, номотор бузилишларни ўрганиш жуда муҳимдир. Мазкур мақолада қисқача адабиёт ва мақолалар кўриб чиқилган бўлиб, Паркинсон касаллигидаги номотор бузилишлар ва уларни даволашдаги турли хил усуллар кўрсатилган.
Библиографические ссылки
Shulman, J.M. De Jager, P.L.,Feany, M.B.,2011. Parkinson’s disease: geneticsand pathogenesis. Annu. Rev. Pathol. 6.
Erik Wolters, Christian Baumann. Parkinson disease and other movement disorders. 2014; 183-190.
Neurobiology of disease 2020 Feb;134:104700. doi: 10.1016/j.nbd.2019.104700. Epub 2019 Dec 3.
Robert B. Daroff, Joseph Jankovic, John C. Mazziotta, Scott L. Pomeroy. Neurology in clinical practice. 2021; 1427-1428.
Neuroscience bulletin 2017 Oct;33(5):515-525. doi: 10.1007/s12264-017-0170-x. Epub 2017 Aug 22.
Experimental neurology 2013 May; 243:57-66. doi:10.1016/j.expneurol.2013.01.014. Epub 2013 Jan 24.
Current treatment options in neurology 2017 Jul;19(7):26. doi: 10.1007/s11940-017-0461-6.
Revista de neurologia 2010 Feb 8;50 Suppl 2:S27-31.
Movement disorders 2011 Oct;26 Suppl 3(0 3):S42-80. doi:10.1002/mds.23884.
Weintraub D, Dietz N, Duda JE, et al. Alzheimer’s disease pattern of brain atrophy predicts cognitive decline in Parkinson’s disease. Brain 2012;135:170-180.
Thobois S, Lhommee E, Klinger H, et all. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 2013;136:1568-1577.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing 2013.
Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society Evidance-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson’s disease.Mov Disord 2011;26S3:42-80.
Ha, A.D., Jankovic, J.,2012.Pain in Parkinson’s disease. Mov. Disord. 27(4), 485-491.
Thenganatt, M.A., Jankovic, J.,2014. Parkinson disease subtypes. JAMA Neurol. 71 (4),499-504.
Kaufmann, H., Freeman, R., Biaggioni, I., et al., 2014. Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial. Neurology 83 (4), 328-335.
Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ. Profile of altered brain iron acquisition in restless legs syndrome. Brain 2011;134:959-968
